MRTFB

MRTFB (MKL2) is a transcriptional coactivator of serum response factor (SRF) that couples actin cytoskeletal dynamics to gene expression programs governing smooth muscle differentiation, neuronal plasticity, megakaryocytopoiesis, and sensory hair cell morphogenesis. MRTFB senses G-actin availability through its RPEL domains: gain-of-function mutations in these domains decrease actin binding and constitutively activate transcription, causing a neurodevelopmental disorder (PMID:37013900). Upon stimulation (e.g., BDNF, dopamine D1R-PKA-MAPK signaling), MAPK phosphorylation of the MRTFB C-terminal domain promotes its nuclear translocation and formation of a ternary complex with SRF and CBP to drive immediate early gene and contractile gene transcription, with partner specificity provided by cofactors such as KLF15 in vascular smooth muscle and TRIM27 in invasive cancer cells (PMID:33449379, PMID:38582447, PMID:24794433). MRTFB also regulates distinct gene sets independently of SRF, as demonstrated by hair cell-specific knockout revealing SRF-independent control of actin cytoskeleton genes essential for stereocilia and cuticular plate integrity (PMID:37982489).

1. 2011 Medium

   Establishing that MRTFB expression is positioned downstream of Wnt2 signaling resolved how smooth muscle transcriptional programs are initiated during lung development, placing MRTFB within a developmental signaling hierarchy.

   Evidence Wnt2 loss- and gain-of-function mouse models with gene expression analysis

   PMID:21704027

   Open questions at the time

   • Whether Wnt2 directly activates Mrtfb transcription or acts through intermediate factors
   • Whether this hierarchy operates in non-pulmonary smooth muscle lineages
2. 2012 High

   Demonstrating that MKL1/MKL2 double knockout in megakaryocytes causes severe defects in platelet formation and cytoskeletal organization established that MRTFB functions redundantly with MKL1 to drive both SRF-dependent and SRF-independent transcription in megakaryocytopoiesis.

   Evidence Megakaryocyte-specific conditional double KO mice with electron microscopy, immunofluorescence, and expression profiling

   PMID:22806889

   Open questions at the time

   • Specific gene targets unique to MRTFB versus MKL1 in megakaryocytes
   • The nature of SRF-independent MRTFB transcriptional programs in this lineage
3. 2013 Low

   Identification of rare MKL2 variants linked to reduced PCTAIRE1 expression in fetal brain provided the first genetic evidence connecting the MKL2:SRF axis to human brain development and microcephaly.

   Evidence Familial exome sequencing, SNP array, targeted immunohistochemistry in fetal cortex

   PMID:23692340

   Open questions at the time

   • Single family study without independent replication
   • No direct demonstration that MKL2 variants are causative rather than contributory
   • Mechanism linking reduced PCTAIRE1 to microcephaly phenotype not established
4. 2014 High

   Discovery of the TRIM27/MRTFB complex revealed an unexpected non-transcriptional role for MRTFB in posttranscriptional regulation of integrin β1 mRNA via miR-124 during collective cancer cell invasion.

   Evidence Co-immunoprecipitation, knockdown, in vitro and in vivo invasion assays

   PMID:24794433

   Open questions at the time

   • Molecular mechanism by which MRTFB/TRIM27 modulates miR-124 activity on integrin β1 mRNA
   • Whether this posttranscriptional role extends beyond cancer invasion contexts
5. 2017 High

   Showing that EWS-FLI1 represses MRTFB activity by occupying overlapping chromatin regions established how an oncogenic fusion disrupts actin cytoskeletal autoregulatory feedback through a MRTFB/YAP-1/TEAD transcriptional module in Ewing sarcoma.

   Evidence ChIP-seq, transcriptome analysis, knockdown experiments in Ewing sarcoma cells

   PMID:28671673

   Open questions at the time

   • Whether restoring MRTFB activity suppresses Ewing sarcoma phenotypes
   • Direct physical interaction between EWS-FLI1 and MRTFB not demonstrated
6. 2018 Medium

   Demonstrating that MKL2 specifically occupies the SARE enhancer of Arc and is required for BDNF-induced Arc transcription in cortical neurons established a neuron-specific, paralog-selective role for MRTFB as an SRF coactivator at activity-regulated genes.

   Evidence ChIP, reporter assays, siRNA knockdown in cultured cortical neurons

   PMID:30244496

   Open questions at the time

   • Whether MRTFB SARE occupancy is stimulus-dependent or constitutive
   • Mechanism conferring MKL2 versus MKL1 specificity at this enhancer
7. 2018 Medium

   Identifying MRTFB as a positive regulator of EDNRB expression in vascular smooth muscle, antagonized by myocardin, revealed context-dependent competition among SRF coactivators at specific target promoters.

   Evidence Overexpression, siRNA silencing, latrunculin B treatment, qPCR in VSMCs

   PMID:30332284

   Open questions at the time

   • Whether MRTFB directly binds the EDNRB promoter or acts indirectly through SRF
   • Physiological consequence of MRTFB-regulated EDNRB in vascular tone
8. 2019 High

   Showing that MRTFB suppresses colorectal cancer invasion and migration through transcriptional targets MCAM and SPDL1 established a tumor-suppressive function, contrasting with its pro-invasive role in other cancer contexts.

   Evidence siRNA, Mrtfb KO mice, xenograft assays, RNA-seq, invasion/migration assays

   PMID:31690663

   Open questions at the time

   • How MCAM and SPDL1 mediate the anti-invasive phenotype mechanistically
   • Whether the tumor-suppressive role is SRF-dependent
9. 2020 Medium

   Discovery of a neuronal isoform (SOLOIST/MRTFB i4) that negatively regulates dendritic complexity, in opposition to isoform 1, revealed isoform-specific functional divergence in MRTFB's control of neuronal morphology and immediate early gene expression.

   Evidence Overexpression in cortical neurons, morphological analysis, reporter and qPCR assays

   PMID:32639614

   Open questions at the time

   • Endogenous expression levels and splicing regulation of MRTFB isoforms in neurons
   • Structural basis for differential SRF coactivation between isoforms
10. 2021 High

    Mapping MAPK phosphorylation on the MRTFB C-terminal domain and showing it promotes nuclear localization and phosphorylation-dependent CBP interaction resolved a key signal-transduction step linking dopamine D1R-PKA-MAPK signaling to SRF-dependent transcription in neurons.

    Evidence Phosphoproteomics, co-immunoprecipitation, domain interaction assays, live-cell imaging, reporter assays

    PMID:33449379

    Open questions at the time

    • Specific phosphorylation sites on the C-terminal domain not fully mapped
    • Whether MAPK-dependent regulation of MRTFB operates in non-neuronal cells
11. 2023 High

    Identifying de novo RPEL-domain mutations (R104G, A91P) that decrease actin binding and constitutively activate MRTFB, causing a neurodevelopmental disorder, provided the definitive mechanistic link between G-actin sensing and human disease.

    Evidence Actin binding assays, Drosophila humanized model, reporter assays, patient variant analysis

    PMID:37013900

    Open questions at the time

    • Full phenotypic spectrum and penetrance of MRTFB gain-of-function variants
    • Which downstream target genes mediate the neurodevelopmental phenotype
12. 2023 High

    Hair cell-specific Mrtfb deletion causing stereocilia and cuticular plate defects, with transcriptome analysis revealing gene targets distinct from SRF targets, established a physiologically essential SRF-independent transcriptional role for MRTFB in inner ear mechanosensory cells.

    Evidence Conditional KO mice, FACS-based hair cell RNA-seq, AAV rescue

    PMID:37982489

    Open questions at the time

    • Identity of the transcription factor(s) MRTFB partners with in SRF-independent regulation
    • Whether SRF-independent MRTFB functions extend to other cell types
13. 2024 Medium

    Demonstrating that KLF15 physically interacts with MRTFB and is required for MRTFB-driven contractile gene expression in VSMCs identified a cofactor that provides target-gene specificity to the MRTFB-SRF axis in vascular biology.

    Evidence Co-immunoprecipitation, Klf15 KO mice, gene expression analysis, siRNA knockdown

    PMID:38582447

    Open questions at the time

    • Whether KLF15 and MRTFB form a complex on chromatin or interact off-DNA
    • Whether KLF15 interaction is exclusive to MRTFB or shared with MKL1/myocardin

• The identity of transcription factor partners mediating MRTFB's SRF-independent transcription, the structural basis for isoform-specific functions, and the full spectrum of downstream targets responsible for neurodevelopmental phenotypes remain unresolved.
• No structural model of MRTFB or its complexes
• SRF-independent partner transcription factors not identified
• Genome-wide direct binding targets in neurons not mapped
• Relative contributions of MRTFB isoforms to disease phenotypes unknown